GISSI-Prevenzione trial (multiple letters) [1]

Lancet

Volumn 354, Issue 9189, 1999, Pages 1554-1557

  Jialal, I ^a   Devaraj, S ^a   Huet, B A ^a   Traber, M ^a   Harrison, R ^a   Burr, M ^a   Elton, P ^a   Salen, P ^a   De Lorgeril, M ^a   Ng, W ^a   Tse, H F ^a   Lau, C P ^a   Singh, R B ^a   Marchioli, R ^a   Tognoni, G ^a   Valagussa, F ^a   Hooper, L ^a   Ness, A ^a   Higgins, J P T ^a   Moore, T ^a   Ebrahim, S ^a   more..

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; FISH OIL; ICOSAPENTAENOIC ACID; LIPID; POLYUNSATURATED FATTY ACID; UBIDECARENONE; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC MICROANGIOPATHY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOG; FISH; HEART DEATH; HEART INFARCTION; HUMAN; HYPERTRIGLYCERIDEMIA; LETTER; LIPID OXIDATION; MAJOR CLINICAL STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL; VITAMIN SUPPLEMENTATION; NOTE;

FATTY ACIDS, OMEGA-3; HUMANS; MYOCARDIAL INFARCTION; VITAMIN E;

EID: 0033619444     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)90191-5     Document Type: Letter

References (0)